Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Russell S Berman

Showing results (61-70 of 99) with videos related to

Pageof 10
Sort By:
The American Journal of Surgical Pathology|May 1, 2013
Mitotic rate in melanoma: prognostic value of immunostaining and computer-assisted image analysisChristopher S Hale, Meng Qian, Michelle W Ma, et al.
Plos One|January 12, 2012
Intra- and inter-tumor heterogeneity of BRAF(V600E))mutations in primary and metastatic melanomaMolly Yancovitz, Adam Litterman, Joanne Yoon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 7, 2016
The Expression Quantitative Trait Loci in Immune Pathways and their Effect on Cutaneous Melanoma PrognosisMatjaz Vogelsang, Carlos N Martinez, Justin Rendleman, et al.
Journal of Translational Medicine|February 25, 2010
Increased shedding of HU177 correlates with worse prognosis in primary melanomaHeather K Hamilton, Amy E Rose, Paul J Christos, et al.
The Journal of Investigative Dermatology|April 26, 2022
Associations between TERT Promoter Mutations and Survival in Superficial Spreading and Nodular Melanomas in a Large Prospective Patient CohortGregory A Chang, Eric Robinson, Jennifer M Wiggins, et al.
Journal of the National Cancer Institute|February 14, 2015
Identification of metastasis-suppressive microRNAs in primary melanomaDoug Hanniford, Miguel F Segura, Judy Zhong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 25, 2010
Melanoma MicroRNA signature predicts post-recurrence survivalMiguel F Segura, Ilana Belitskaya-Lévy, Amy E Rose, et al.
Pigment Cell & Melanoma Research|October 2, 2010
Clinical relevance of SKP2 alterations in metastatic melanomaAmy E Rose, Guimin Wang, Douglas Hanniford, et al.
Oncology|June 25, 2011
A high proliferative index of recurrent melanoma is associated with worse survivalTing J Tu, Michelle W Ma, Stefano Monni, et al.
Neuro-Oncology|May 8, 2012
Challenging the current paradigm of melanoma progression: brain metastasis as isolated first visceral siteMichelle W Ma, Meng Qian, Daniel J Lackaye, et al.
Pageof 10

Showing results (61-70 of 99) with videos related to

Sort By:
Pageof 10
The American Journal of Surgical Pathology|May 1, 2013
Mitotic rate in melanoma: prognostic value of immunostaining and computer-assisted image analysisChristopher S Hale, Meng Qian, Michelle W Ma, et al.
Plos One|January 12, 2012
Intra- and inter-tumor heterogeneity of BRAF(V600E))mutations in primary and metastatic melanomaMolly Yancovitz, Adam Litterman, Joanne Yoon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 7, 2016
The Expression Quantitative Trait Loci in Immune Pathways and their Effect on Cutaneous Melanoma PrognosisMatjaz Vogelsang, Carlos N Martinez, Justin Rendleman, et al.
Journal of Translational Medicine|February 25, 2010
Increased shedding of HU177 correlates with worse prognosis in primary melanomaHeather K Hamilton, Amy E Rose, Paul J Christos, et al.
The Journal of Investigative Dermatology|April 26, 2022
Associations between TERT Promoter Mutations and Survival in Superficial Spreading and Nodular Melanomas in a Large Prospective Patient CohortGregory A Chang, Eric Robinson, Jennifer M Wiggins, et al.
Journal of the National Cancer Institute|February 14, 2015
Identification of metastasis-suppressive microRNAs in primary melanomaDoug Hanniford, Miguel F Segura, Judy Zhong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 25, 2010
Melanoma MicroRNA signature predicts post-recurrence survivalMiguel F Segura, Ilana Belitskaya-Lévy, Amy E Rose, et al.
Pigment Cell & Melanoma Research|October 2, 2010
Clinical relevance of SKP2 alterations in metastatic melanomaAmy E Rose, Guimin Wang, Douglas Hanniford, et al.
Oncology|June 25, 2011
A high proliferative index of recurrent melanoma is associated with worse survivalTing J Tu, Michelle W Ma, Stefano Monni, et al.
Neuro-Oncology|May 8, 2012
Challenging the current paradigm of melanoma progression: brain metastasis as isolated first visceral siteMichelle W Ma, Meng Qian, Daniel J Lackaye, et al.
Pageof 10